# Vidur Mahajan

> Dr. Vidur Mahajan is the physician-MBA founder and CEO of CARPL.ai, a vendor-neutral platform for testing, deploying, procuring and monitoring radiology AI. After helping run his family's imaging-center business in India and its research group, he turned an internal analytics project into a platform now offering more than 300 applications from over 100 partners. CARPL raised a $10 million Series A led by IFC in July 2026, bringing its publicly announced funding total to $16 million.

- **Role:** Founder and Chief Executive Officer at CARPL.ai
- **Organizations:** CARPL.ai, Mahajan Imaging, Center for Advanced Research in Imaging, Neurosciences and Genomics, Wharton School
- **Education:** MBBS, Medicine, Lokmanya Tilak Municipal Medical College, Mumbai, MBA, Finance and Health Care Management, The Wharton School, University of Pennsylvania
- **Known for:** Built CARPL from an internal radiology analytics project into a platform offering more than 300 AI applications from over 100 partners by July 2026., Raised $16 million in announced seed and Series A funding for CARPL across 2024 and 2026., Co-authored a 2018 Lancet study validating deep-learning algorithms on a dataset of more than 313,000 head CT scans.

## Career timeline

- **2009-2010** — Worked in medical internships and residency roles after completing his MBBS.
- **2010-2014** — Served at Mahajan Imaging, the family radiology-center business, before leaving for business school.
- **2014-2016** — Completed an MBA at Wharton with dual majors in finance and health care management; co-chaired the Wharton India Economic Forum and led the Wharton India Club.
- **2016-2021** — Returned to Mahajan Imaging as an associate director and led work connected to the CARING research group.
- **2018** — Co-authored a Lancet study on deep-learning detection of critical findings in more than 313,000 head CT scans.
- **2021** — Began serving as founder and CEO of CARPL.ai, developed from the CARING Analytics Platform.
- **2024** — CARPL announced a $6 million seed round and received FDA 510(k) clearance for its medical image management and processing system.
- **2026** — CARPL raised a $10 million Series A led by IFC, with participation from Stellaris Venture Partners and other investors.

## Achievements

- Built CARPL from an internal radiology analytics project into a platform offering more than 300 AI applications from over 100 partners by July 2026.
- Raised $16 million in announced seed and Series A funding for CARPL across 2024 and 2026.
- Co-authored a 2018 Lancet study validating deep-learning algorithms on a dataset of more than 313,000 head CT scans.
- Published or co-authored more than 120 academic and conference papers in AI and imaging, according to his public speaker biographies.
- Led CARPL through FDA 510(k) clearance in 2024 for its medical image management and processing system.
- Expanded CARPL to customers and public-sector use across multiple countries, including Brazil, India, Singapore, Spain and the UAE.

## Latest updates

- **2026-07** — CARPL announced a $10 million Series A led by IFC, with participation from Stellaris Venture Partners and other investors.
- **2026-07** — A Stellaris podcast highlighted that CARPL was processing approximately 130,000 patient scans per month.
- **2026-06** — CARPL announced a partnership with Enlitic to speed the preparation of imaging data for AI validation.
- **2025-01** — Intelerad announced that CARPL had joined its AI partner ecosystem, making CARPL's marketplace available through the InteleGence integration platform.

## Links

- Website: https://carpl.ai
- LinkedIn: https://www.linkedin.com/in/drvidurmahajan
- Twitter/X: https://twitter.com/CARPLai
- YouTube: https://www.youtube.com/watch?v=wzG6GqydiUE

---

Profile page: https://yespress.io/vidur-carpl
Published by YesPress — https://yespress.io
Last updated: 2026-09-26